Lu Kang Pharmaceutical (600789.SH) plans to invest 194 million yuan to construct a continuous intelligent manufacturing project for chemical raw materials.

Zhitong Finance APP reported that Lu Kang Pharmaceutical (600789.SH) issued an announcement stating that in order to enhance the scale and profitability of its active pharmaceutical ingredients (APIs), the company plans to invest approximately 194 million yuan to establish a cost-effective production model that integrates intermediates, APIs, and formulations. This project aims to enrich the product structure of APIs and improve the capacity for associated formulations. The construction period of the project is expected to be 18 months.